Metraipolis › archive › dc_cd68587f9652

Safety and efficacy of remimazolam in critical illness — Europe PMC PMID:41578403

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41578403
DOI: 10.1186/s40560-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-11-06T13:32:24.711Z
SHA-256 of the archived text: 642cfd5de0f2c3052e6ae1a75370b3ed03d0d6e7f5ad7839279d7f30cd1cd7a6
Stable URL of this page: https://metraipolis.com/documento/dc_cd68587f9652

How to cite

Safety and efficacy of remimazolam in critical illness — Europe PMC PMID:41578403 — Europe PMC (en), https://europepmc.org/article/MED/41578403 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd68587f9652 (Metraipolis archive dc_cd68587f9652, sha256 642cfd5de0f2c3052e6ae1a75370b3ed03d0d6e7f5ad7839279d7f30cd1cd7a6)

BibTeX

@misc{dccd68587f9652,
  title = {Safety and efficacy of remimazolam in critical illness — Europe PMC PMID:41578403},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41578403},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd68587f9652; sha256 642cfd5de0f2c3052e6ae1a75370b3ed03d0d6e7f5ad7839279d7f30cd1cd7a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578403. Agents can read the archived copy with the MCP tool read_document.